- Genor Biopharma Co. Ltd is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs.
- We have successfully developed drug candidates targeting pathways with blockbuster potentials, encompassing top three oncology targets and five out of the ten bestselling drugs globally.
- We have leveraged primarily in-house capabilities in establishing a pipeline of 15 targeted drug candidates with tremendous commercialization potentials in China that cover both proven and novel biological pathways.
Latest News
-
2022-06-24Genor Biopharma and Abogen Biosciences Announce a Cooperative Development Agreement to Jointly Develop Globally Innovative mRNA Products and Related Pharmaceuticals
-
2022-06-06Genor Biopharma obtains IND approval from NMPA to commence the phase I/II clinical trial of GB263T, the world's first EGFR/cMET/cMET tri-specific antibody
-
2022-05-24Genor Biopharma obtains IND approval to commence the phase I/II clinical trial of GB261
Find Out More
